Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Author(s):
Langlois, M.R.; Chapman, M.J.; Cobbaert, C.; Mora, S.; Remaley, A.T.; Ros, E.; Watts, G.F.; Boren, J.; Baum, H.; Bruckert, E.; Catapano, A.; Descamps, O.S.; Eckardstein, A. von; Kamstrup, P.R.; Kolovou, G.; Kronenberg, F.; Langsted, A.; Pulkki, K.; Rifai, N.; Sypniewska, G.; Wiklund, O.; Nordestgaard, B.G.; EAS; European Federation Clinical Ch
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-07-31
Language
English
Is part of
Clinical Chemistry (2018), Vol. 64, no. 7, p. 1006-1033
hdl
1887/95599
doi
10.1373/clinchem.2018.287037